中信证券：预计新冠小分子口服药和新冠相关中药将是未来新冠防控重要保障

array(1) { [465925]=> array(2) { [2]=> array(5) { [0]=> string(6) "中药" [1]=> string(18) "中信证券研报" [2]=> string(12) "新冠疫情" [3]=> string(11) "XD中信证" [4]=> string(12) "连锁药店" } [4]=> array(1) { [0]=> string(19) "同花顺7x24快讯" } } }